Robot or scalpel? european trial tests less invasive pancreatic cancer surgery

NCT ID NCT04483726

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial compares two types of surgery for pancreatic cancer in the body or tail of the pancreas: minimally invasive (laparoscopic or robot-assisted) versus traditional open surgery. The goal is to see if the less invasive approach can remove the tumor just as completely. Adults with resectable pancreatic cancer who are fit for either surgery type may join.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
minimally invasive distal pancreatectomy (laparoscopic or robot-assisted)
What this could lead to
If minimally invasive surgery proves as effective as open surgery, it could offer patients a less painful recovery with similar cancer outcomes.
What could go wrong
This is a relatively small early-phase trial, so results may not be definitive. Minimally invasive surgery may not remove the tumor as completely as open surgery in some cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Saint Eloi - Montpellier

    Montpellier, France

  • Centre Hospitalier Orléans

    Orléans, France

  • Hôpital Beaujon - APHP

    Clichy, France

  • Hôpital Paul Brousse

    Villejuif, France

  • Institut Mutualiste Montsouris

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.